Kewaunee Scientific (KEQU) Liabilities and Shareholders Equity (2011 - 2026)

Kewaunee Scientific's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $178.3 million for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity fell 8.4% year-over-year to $178.3 million; the TTM figure through Apr 2026 stood at $736.8 million (up 13.31% YoY), while the FY2026 annual figure was $178.3 million, down 8.4% from the prior year.
• Liabilities and Shareholders Equity for Q2 2026 stood at $178.3 million, up from $176.0 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $194.7 million in Q2 2025, with the low at $95.7 million in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $129.2 million (2024), against an average of $144.1 million.
• The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity jumped 49.75% in 2025, then declined 8.4% in 2026.
• Kewaunee Scientific's Liabilities and Shareholders Equity stood at $119.1 million in 2022, then rose by 2.17% to $121.7 million in 2023, then rose by 10.49% to $134.5 million in 2024, then soared by 40.6% to $189.1 million in 2025, then decreased by 5.69% to $178.3 million in 2026.
• Business Quant data shows KEQU's Liabilities and Shareholders Equity at $178.3 million in Q2 2026, $176.0 million in Q1 2026, and $189.1 million in Q4 2025.